Maple Syrup Urine Disease

This is a rare genetic condition. It affects how your body breaks down certain proteins. This causes a buildup of waste products that give urine and sweat a sweet smell, like maple syrup. It can cause serious health problems if not treated early.

Condition

What people with Maple Syrup Urine Disease report

Every report comes from a Lived member, sent anonymously.

Have you tried Low-Protein Diet for Maple Syrup Urine Disease?

NameHow it went

About Maple Syrup Urine Disease

What It Is

Maple syrup urine disease (MSUD) is a rare inherited metabolic disorder in which the body cannot properly break down three amino acids found in protein: leucine, isoleucine and valine, known together as the branched-chain amino acids. Because the enzyme that normally processes them works poorly or not at all, these amino acids and their byproducts build up in the blood. High levels, especially of leucine, are toxic to the brain. The condition is named for the sweet, maple syrup-like smell that the buildup can give to urine and earwax. The most common and severe form, classic MSUD, causes symptoms within the first few days of life: poor feeding, unusual sleepiness, irritability and vomiting, followed without treatment by abnormal movements, seizures and coma. Milder variant forms (intermediate, intermittent and thiamine-responsive) leave more enzyme activity and usually show up later in infancy or childhood, often during an illness. In every form, the central danger is a metabolic crisis, a rapid rise in leucine that can injure the brain, so MSUD is managed as a lifelong condition even when someone is well most of the time.

Causes & Risk Factors

MSUD is caused by changes in one of a small group of genes that together build the enzyme complex needed to break down branched-chain amino acids. It is inherited in an autosomal recessive pattern: a child is affected only when both parents pass on a changed copy. Parents who each carry one copy are usually healthy, and in each pregnancy they have a 25% chance of having a child with MSUD. The condition is rare overall, about 1 in 185,000 births worldwide, but much more common in some communities where a particular variant is shared, such as Old Order Mennonite families in the United States. Once someone has MSUD, certain situations can set off a crisis. Infection, fever, injury, surgery and going too long without eating all push the body to break down its own protein, releasing leucine faster than it can be cleared. Eating more protein than the person's personal limit has a similar effect. These triggers do not cause MSUD, but they explain why a person who is usually stable can become unwell quickly.

How It's Diagnosed

In the United States and many other countries, MSUD is part of routine newborn screening, a heel-prick blood test taken in the first days of life. A positive screen is not a diagnosis, but it calls for same-day follow-up testing, because infants with classic MSUD can become seriously ill within days. Some babies with severe MSUD become sick before screening results return, and milder forms can be missed because levels may look normal when the baby is well. The key confirmatory test measures amino acids in a blood sample. A substance called alloisoleucine, which is almost undetectable in people without MSUD, is a reliable marker of all forms of the condition. Urine tests for organic acids and ketones support the diagnosis, and genetic testing identifies the responsible gene changes. Genetic results also make carrier testing for relatives and testing in future pregnancies possible. Ideally, diagnosis and treatment planning happen at a specialist center for inherited metabolic diseases.

Treatment Options

The foundation of treatment is a lifelong diet that limits natural protein so that leucine stays within a safe range, while still providing enough nutrition to grow and stay healthy. Because all ordinary protein foods contain branched-chain amino acids, most protein comes from a special medical formula that supplies the other amino acids without them. Valine and isoleucine supplements are often added because the diet can push their levels too low. Each person's tolerance is different, so a metabolic dietitian adjusts the plan based on regular blood tests, which are frequent in early childhood and less frequent later. Every person with MSUD should also have a written sick-day plan from their metabolic team. At the first sign of illness, it typically means cutting back or stopping natural protein, increasing the special formula and taking frequent sugary drinks or feeds to stop the body from breaking down its own protein, while contacting the team for guidance. When this is not enough, hospital treatment uses intravenous sugar and fat, protein-free nutrition and sometimes dialysis to lower leucine quickly. A small number of people have thiamine-responsive MSUD, in which high doses of thiamine (vitamin B1) help the remaining enzyme work better; thiamine is always used together with a protein-restricted diet, not instead of it. For severe MSUD, liver transplantation is an established option. A new liver supplies enough enzyme for most people to eat a normal diet and greatly lowers the risk of crises, but it involves major surgery, depends on donor availability, does not reverse brain injury that has already happened, and still requires lifelong follow-up. Gene therapy is being researched but is not an available treatment.

What to Expect

With early diagnosis and careful management, many children with MSUD grow into adulthood and stay healthy. Outcomes depend heavily on how quickly treatment started and how well leucine levels are controlled, particularly in the first years of life. People with classic MSUD have a higher chance of learning difficulties, attention problems, anxiety or depression, and some develop thin bones, so development, mental health and bone health are worth monitoring over time. Daily life involves weighing and planning food, taking formula several times a day, regular blood tests and clinic visits, and keeping the sick-day plan close at hand, including when traveling. The restricted diet can make social meals and school or work events harder, and many families describe the constant watchfulness for illness as a significant strain, so dietitian, psychological and peer support are part of good care. The amount of leucine a person can eat changes as they grow, and the team adjusts it, but the risk of a crisis does not disappear. Keeping to the diet over the long term is often hardest for adults. People with intermittent MSUD may eat fairly normally between episodes but still need a plan for illness. Pregnancy is possible but needs close metabolic monitoring, especially just after delivery.

When to Seek Help

If a newborn screen is positive for MSUD, follow up with the screening program or clinician right away, the same day if possible. If that baby, or any newborn with a family history of MSUD, is already feeding poorly, vomiting or unusually sleepy, seek emergency care rather than waiting for follow-up. A family history of MSUD is a reason to ask about genetic counseling and carrier testing before or during pregnancy. For someone already diagnosed, contact the metabolic team as soon as a fever, infection, injury, upcoming surgery or reduced appetite begins, and start the sick-day plan. Seek emergency care if a baby feeds poorly or is unusually sleepy or difficult to wake. At any age, seek emergency care for repeated vomiting or being unable to keep down formula, confusion or a change in alertness, unsteady walking, unusual movements or a seizure. These can be signs of a crisis that may lead to dangerous brain swelling, and early hospital treatment can prevent lasting damage.

Questions to Ask Your Doctor

  1. 1.Which form of MSUD do I or my child have, and how does that change our risk of a crisis?
  2. 2.What is our personal leucine target, how often should blood levels be checked, and how do we adjust the diet as we grow older?
  3. 3.What exactly should our sick-day plan say, and at what point should we stop managing at home and go to the hospital?
  4. 4.Would a thiamine trial or liver transplantation be worth considering in our situation, and what are the realistic trade-offs?
  5. 5.What support is available for school, work, mental health and the day-to-day burden of the diet?

Last reviewed • Oct 2026

Educational content, not medical advice.